Literature DB >> 9428341

The paradox of neoplastic glial cell invasion of the brain and apparent metastatic failure.

G J Pilkington1.   

Abstract

Brain tumours fall into 3 major categories: a) secondary tumours which have originated in distant parts of the body, b) meningiomas, which generally grow on, rather than in, the substance of the brain and c) intrinsic tumours which are generally composed of neoplastic glial cells. Secondary tumours show a marked propensity for metastasis to, and growth in, the brain; up to 24% of cancers are thought to metastasize to the brain. These metastatic deposits are frequently multiple but are usually well circumscribed lesions. Meningiomas are usually benign lesions which grow by expansion and seeding along the leptomeninges on the surface of the brain. Such tumours may, however, recur and show some degree of invasion of the underlying cerebral cortex. The most common form of brain tumour is the glioma, of which there are various histological types. These tumours generally fail to metastasize out of the nervous system. Two plausable explanations for this failure have been recently proposed. Firstly, the vascular basal laminae of the brain appears to exclude intravasation of neoplastic glia and secondly, if such cells do enter the vascular system they are prevented from binding to the endothelial cells of "target" organs by virtue of a lack of appropriate cell adhesion molecules, including CD 15. While intrinsic glial tumours fail to metastasize they are, however, characterised by diffuse local invasion of the normal nervous tissues. This important biological feature hampers all current therapeutic approaches. Local invasion is a multi-faceted phenomenon of interactive mechanisms including cell motility, adhesion and enzymic remodelling of the extracellular matrix components and involves paracrine interaction between normal and neoplastic cellular elements.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428341

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

Review 1.  Extraneural metastases of primary brain tumors.

Authors:  T Schweitzer; G H Vince; C Herbold; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

2.  The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.

Authors:  Marie-Annick Forget; Richard R Desrosiers; MaestroRolandaF Del; Robert Moumdjian; Daniel Shedid; France Berthelet; Richard Béliveau
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Glioma Cell Invasion is Significantly Enhanced in Composite Hydrogel Matrices Composed of Chondroitin 4- and 4,6-Sulfated Glycosaminoglycans.

Authors:  Meghan T Logun; Nicole S Bisel; Emily A Tanasse; Wujun Zhao; Bhagya Gunasekera; Leidong Mao; Lohitash Karumbaiah
Journal:  J Mater Chem B       Date:  2016-08-26       Impact factor: 6.331

4.  Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.

Authors:  Maode Wang; Daizo Yoshida; Shouxun Liu; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

5.  Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells.

Authors:  Yong Lu; Feng Jiang; Hao Jiang; Kalina Wu; Xuguang Zheng; Yizhong Cai; Mark Katakowski; Michael Chopp; Shing-Shun Tony To
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

Review 6.  Lysosomal enzymes, cathepsins in brain tumour invasion.

Authors:  Natasa Levicar; Tadej Strojnik; Janko Kos; Ricardo A Dewey; Geoffrey J Pilkington; Tamara T Lah
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 7.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

8.  Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.

Authors:  Bin Hu; Keerthi K Thirtamara-Rajamani; Hosung Sim; Mariano S Viapiano
Journal:  Mol Cancer Res       Date:  2009-11-03       Impact factor: 5.852

9.  The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.

Authors:  Bin Hu; Leopold L Kong; Russell T Matthews; Mariano S Viapiano
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

10.  BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.

Authors:  Mariano Sebastian Viapiano; Susan Hockfield; Russell Thomas Matthews
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.